{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:26:07Z","timestamp":1788607567942,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zunyi Science and Technology Bureau","award":["HZ-2023-183,[2021]1350-019"],"award-info":[{"award-number":["HZ-2023-183,[2021]1350-019"]}]},{"name":"Doctor Start Fund of Zunyi Medical University","award":["F-1055"],"award-info":[{"award-number":["F-1055"]}]},{"name":"Guizhou Provincial Basic Research Programm","award":["MS[2025]382"],"award-info":[{"award-number":["MS[2025]382"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2026-500"],"award-info":[{"award-number":["gzwkj2026-500"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82460711"],"award-info":[{"award-number":["No. 82460711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004001","name":"Science and Technology Foundation of Guizhou Province","doi-asserted-by":"crossref","award":["ZYD[2025]022, ZD[2026]163 and KJLYRC-[2026]038)"],"award-info":[{"award-number":["ZYD[2025]022, ZD[2026]163 and KJLYRC-[2026]038)"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11121-8","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:07:37Z","timestamp":1783148857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Limosilactobacillus reuteri Alleviates Parkinson\u2019s Disease by Regulating CDCA Secretion"],"prefix":"10.1007","author":[{"given":"Daidi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-3640","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"1","key":"11121_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13041-025-01218-6","volume":"18","author":"GS Rocha","year":"2025","unstructured":"Rocha GS, Freire MAM, Falcao D, Outeiro TF, Lima RR, Santos JR (2025) Neurodegeneration in Parkinson\u2019s disease: are we looking at the right spot? Mol Brain 18(1):68. https:\/\/doi.org\/10.1186\/s13041-025-01218-6","journal-title":"Mol Brain"},{"issue":"5","key":"11121_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL (2024) Parkinson\u2019s Disease. N Engl J Med 391(5):442\u2013452. https:\/\/doi.org\/10.1056\/NEJMra2401857","journal-title":"N Engl J Med"},{"issue":"5","key":"11121_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/s1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"11121_CR4","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/s41467-023-38248-4","volume":"14","author":"B Huang","year":"2023","unstructured":"Huang B, Chau SWH, Liu Y et al (2023) Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat Commun 14(1):2501. https:\/\/doi.org\/10.1038\/s41467-023-38248-4","journal-title":"Nat Commun"},{"issue":"12","key":"11121_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi F, Bravi D, Emmi A, Antonini A (2024) Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol 20(12):695\u2013707. https:\/\/doi.org\/10.1038\/s41582-024-01034-x","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"11121_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS et al (2024) Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"11121_CR7","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Wang Q, Luo Y, Ray Chaudhuri K, Reynolds R, Tan EK, Pettersson S (2021) The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain 144(9):2571\u20132593. https:\/\/doi.org\/10.1093\/brain\/awab156","journal-title":"Brain"},{"issue":"1","key":"11121_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ et al (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9(1):226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9","journal-title":"Microbiome"},{"issue":"8","key":"11121_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","volume":"42","author":"H Mirzaei","year":"2022","unstructured":"Mirzaei H, Sedighi S, Kouchaki E et al (2022) Probiotics and the Treatment of Parkinson\u2019s Disease: An Update. Cell Mol Neurobiol 42(8):2449\u20132457. https:\/\/doi.org\/10.1007\/s10571-021-01128-w","journal-title":"Cell Mol Neurobiol"},{"issue":"9","key":"11121_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM et al (2023) Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell 186(9):1846\u20131862e1826. https:\/\/doi.org\/10.1016\/j.cell.2023.03.011","journal-title":"Cell"},{"issue":"6","key":"11121_CR11","doi-asserted-by":"publisher","first-page":"e13017","DOI":"10.1111\/hel.13017","volume":"28","author":"NI Ismail","year":"2023","unstructured":"Ismail NI, Nawawi KNM, Hsin DCC et al (2023) Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Helicobacter 28(6):e13017. https:\/\/doi.org\/10.1111\/hel.13017","journal-title":"Helicobacter"},{"issue":"3","key":"11121_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ (2022) Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe 30(3):289\u2013300. https:\/\/doi.org\/10.1016\/j.chom.2022.02.004","journal-title":"Cell Host Microbe"},{"issue":"1","key":"11121_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing C, Huang X, Wang D et al (2023) Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci 13(1):106. https:\/\/doi.org\/10.1186\/s13578-023-01053-z","journal-title":"Cell Biosci"},{"key":"11121_CR14","doi-asserted-by":"publisher","unstructured":"Teodoro JS, Machado IF, Castela AC et al (2021) Chenodeoxycholic Acid Has Non-Thermogenic, Mitodynamic Anti-Obesity Effects in an In Vitro CRISPR\/Cas9 Model of Bile Acid Receptor TGR5 Knockdown. Int J Mol Sci 22(21). https:\/\/doi.org\/10.3390\/ijms222111738","DOI":"10.3390\/ijms222111738"},{"issue":"8","key":"11121_CR15","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1210\/jc.2012-4109","volume":"98","author":"AC Meyer-Gerspach","year":"2013","unstructured":"Meyer-Gerspach AC, Steinert RE, Keller S, Malarski A, Schulte FH, Beglinger C (2013) Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans. J Clin Endocrinol Metab 98(8):3351\u20133358. https:\/\/doi.org\/10.1210\/jc.2012-4109","journal-title":"J Clin Endocrinol Metab"},{"key":"11121_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J, Li H, Jin Y et al (2021) Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 91:703\u2013715. https:\/\/doi.org\/10.1016\/j.bbi.2020.10.014","journal-title":"Brain Behav Immun"},{"key":"11121_CR17","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89:101979. https:\/\/doi.org\/10.1016\/j.arr.2023.101979","journal-title":"Ageing Res Rev"},{"key":"11121_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen ZD, Appah M, Dean MN et al (2020) Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 6:11. https:\/\/doi.org\/10.1038\/s41531-020-0112-6","journal-title":"NPJ Parkinsons Dis"},{"key":"11121_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease. Ageing Res Rev 45:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"key":"11121_CR20","doi-asserted-by":"publisher","first-page":"1254198","DOI":"10.3389\/fcimb.2023.1254198","volume":"13","author":"Y Peng","year":"2023","unstructured":"Peng Y, Ma Y, Luo Z, Jiang Y, Xu Z, Yu R (2023) Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. Front Cell Infect Microbiol 13:1254198. https:\/\/doi.org\/10.3389\/fcimb.2023.1254198","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"11121_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/19490976.2020.1734423","volume":"11","author":"H Wu","year":"2020","unstructured":"Wu H, Xie S, Miao J et al (2020) Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa. Gut Microbes 11(4):997\u20131014. https:\/\/doi.org\/10.1080\/19490976.2020.1734423","journal-title":"Gut Microbes"},{"key":"11121_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2021.07.026","volume":"98","author":"V Leta","year":"2021","unstructured":"Leta V, Ray Chaudhuri K, Milner O et al (2021) Neurogenic and anti-inflammatory effects of probiotics in Parkinson\u2019s disease: A systematic review of preclinical and clinical evidence. Brain Behav Immun 98:59\u201373. https:\/\/doi.org\/10.1016\/j.bbi.2021.07.026","journal-title":"Brain Behav Immun"},{"issue":"2","key":"11121_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15321819.2020.1833917","volume":"42","author":"E Alipour Nosrani","year":"2021","unstructured":"Alipour Nosrani E, Tamtaji OR, Alibolandi Z et al (2021) Neuroprotective effects of probiotics bacteria on animal model of Parkinson\u2019s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. J Immunoass Immunochem 42(2):106\u2013120. https:\/\/doi.org\/10.1080\/15321819.2020.1833917","journal-title":"J Immunoass Immunochem"},{"key":"11121_CR24","doi-asserted-by":"publisher","unstructured":"Li P, Killinger BA, Ensink E et al (2021) Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson\u2019s Disease. Metabolites 11(1). https:\/\/doi.org\/10.3390\/metabo11010029","DOI":"10.3390\/metabo11010029"},{"issue":"21","key":"11121_CR25","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1021\/acschemneuro.4c00459","volume":"15","author":"H Kaur","year":"2024","unstructured":"Kaur H, Swadia D, Sinha S (2024) Bile Acids as Modulators of \u03b1-Synuclein Aggregation: Implications for Parkinson\u2019s Therapy. ACS Chem Neurosci 15(21):4055\u20134065. https:\/\/doi.org\/10.1021\/acschemneuro.4c00459","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"11121_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-022-00307-z","volume":"11","author":"K Khalaf","year":"2022","unstructured":"Khalaf K, Tornese P, Cocco A, Albanese A (2022) Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. Transl Neurodegener 11(1):33. https:\/\/doi.org\/10.1186\/s40035-022-00307-z","journal-title":"Transl Neurodegener"},{"key":"11121_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.freeradbiomed.2025.04.053","volume":"235","author":"C Ni","year":"2025","unstructured":"Ni C, Wang L, Bai Y et al (2025) Taurochenodeoxycholic acid activates autophagy and suppresses inflammatory responses in microglia of MPTP-induced Parkinson\u2019s disease mice via AMPK\/mTOR, AKT\/NF\u03baB and Pink1\/Parkin signaling pathways mediated by Takeda G protein-coupled receptor 5. Free Radic Biol Med 235:347\u2013363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.04.053","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11121_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12035-025-05619-5","volume":"63","author":"D Qi","year":"2025","unstructured":"Qi D, Yi R, Yang J et al (2025) Tauroursodeoxycholic Acid Inhibits NF-\u03baB\/p300\/H3K14ac to Attenuate Microglial Activation in Lipopolysaccharide-treated BV-2 Cells and Mice. Mol Neurobiol 63(1):295. https:\/\/doi.org\/10.1007\/s12035-025-05619-5","journal-title":"Mol Neurobiol"},{"key":"11121_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuroscience.2025.03.050","volume":"573","author":"M Mehreen","year":"2025","unstructured":"Mehreen M, Ali M, Tariq H, Noor A, Mumtaz S, Zafar S (2025) Chenodeoxycholic Acid-Mediated neuroprotection via \u03b1-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson\u2019s disease. Neuroscience 573:442\u2013450. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.050","journal-title":"Neuroscience"},{"issue":"2","key":"11121_CR30","doi-asserted-by":"publisher","first-page":"2274124","DOI":"10.1080\/19490976.2023.2274124","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Lin H, Shen C et al (2023) Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling. Gut Microbes 15(2):2274124. https:\/\/doi.org\/10.1080\/19490976.2023.2274124","journal-title":"Gut Microbes"},{"key":"11121_CR32","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH (2022) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol Res 186:106550. https:\/\/doi.org\/10.1016\/j.phrs.2022.106550","journal-title":"Pharmacol Res"},{"key":"11121_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.clnesp.2024.06.034","volume":"63","author":"CS Kow","year":"2024","unstructured":"Kow CS, Ramachandram DS, Hasan SS, Thiruchelvam K (2024) Beyond metformin: The promise of glucagon-like peptide-1 receptor agonists for neuroprotection in Parkinson\u2019s disease. Clin Nutr ESPEN 63:184\u2013185. https:\/\/doi.org\/10.1016\/j.clnesp.2024.06.034","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"11121_CR35","doi-asserted-by":"publisher","first-page":"e10505","DOI":"10.1002\/btm2.10505","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen WJ, Han YY et al (2023) Neuroprotective effect of engineered Clostridiumbutyricum-pMTL007-GLP-1 on Parkinson\u2019s disease mice models via promoting mitophagy. Bioeng Transl Med 8(3):e10505. https:\/\/doi.org\/10.1002\/btm2.10505","journal-title":"Bioeng Transl Med"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11121-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11121-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:07:39Z","timestamp":1783148859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11121-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":33,"alternative-id":["11121"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11121-8","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the Chinese Guidelines of Animal Care and Welfare. All experimental procedures were approved by the Animal Care and Use Committee of Zunyi Medical University (Zunyi, China) (Approval No. ZMU21-2403-379).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}